• Explore /
  • Poster
  • / Adjuvant or neoadjuvant chemotherapy in early stage triple negative breast cancer (TNBC) comparison of outcomes in both BRCA positive and BRCA negative patients.

Adjuvant or neoadjuvant chemotherapy in early stage triple negative breast cancer (TNBC) comparison of outcomes in both BRCA positive and BRCA negative patients.

Abstract Poster

Authors

null

Katherine Clifton

The University of Texas MD Anderson Cancer Center, Houston, TX

Katherine Clifton , Angelica Gutierrez Barrera , Junsheng Ma , Roland L. Bassett Jr., Jennifer Keating Litton , Banu Arun

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Neoadjuvant Therapy

Citation

J Clin Oncol 35, 2017 (suppl; abstr 576)

DOI

10.1200/JCO.2017.35.15_suppl.576

Abstract #

576

Poster Bd #

176

Abstract Disclosures

Similar Posters

First Author: Charles E. Geyer Jr.

Poster

2012 ASCO Annual Meeting

Racial differences in outcomes of triple-negative breast cancer.

Racial differences in outcomes of triple-negative breast cancer.

First Author: Jose Pacheco

First Author: Agust Barnadas

First Author: Rixci Ramirez